Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc. (ALZN) Q2 2024 Annual Earnings

ALZN·Reported July 30, 2024·Before market open

Alzamend Neuro, Inc. reported Q2 2024 revenue of $76.1K. Diluted EPS came in at $-13.35, missed the $-2.75 consensus by $10.60.

Revenue
$76.1K
Diluted EPS
$-13.35missed by $10.60
Consensus: $-2.75
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q2 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about Alzamend Neuro, Inc.'s Q2 2024 earnings report.

Alzamend Neuro, Inc. (ALZN) reported Q2 2024 earnings on July 30, 2024 before market open.

Alzamend Neuro, Inc. reported revenue of $76.1K and diluted EPS of $-13.35 for Q2 2024.

EPS missed the consensus estimate of $-2.75 by $10.60.

You can read the 10-K periodic report (0001214659-24-013191) directly on SEC EDGAR. The filing index links above go to sec.gov.